Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccines.

A Reyes-Sandoval1, H C Ertl

  • 1The Wistar Institute, Philadelphia, PA 19104, USA.

Current Molecular Medicine
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Plasmid DNA vaccines offer a versatile platform for disease prevention and treatment, demonstrating potential against infections and cancer in animal models. Further optimization is needed to enhance their efficacy in human clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Mucosal immunology·2015
Same author

Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.

Journal of virology·2014
Same author

Protection of non-human primates against rabies with an adenovirus recombinant vaccine.

Virology·2014
Same author

Influenza virus specific CD8⁺ T cells exacerbate infection following high dose influenza challenge of aged mice.

BioMed research international·2013
Same author

CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Journal of virology·2013
Same author

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.

Clinical and vaccine immunology : CVI·2013
Same journal

Corrigendum to: Sortilin as a Culprit in the Atherosclerosis Plaque Progression: Evidence from Clinical and Experimental Studies.

Current molecular medicine·2026
Same journal

Dynamic Expression of Fibroblast Activation Protein (FAP) During Chronic Pancreatitis (CP) Progression in Mice and Evaluation of FAP-targeted Tracers for Early CP Diagnosis.

Current molecular medicine·2026
Same journal

Causal Relationship Between 91 Inflammatory Factors and Gastritis: A Two-Sample Bidirectional Mendelian Randomization Study.

Current molecular medicine·2026
Same journal

Therapeutic Potential of Pistacia Atlantica Gum in Aspirin-Induced Peptic Ulcers: A Dose-Dependent Approach to Mucosal Protection and Hepatorenal Safety.

Current molecular medicine·2026
Same journal

Identification and Characterization of MicroRNAs Associated with Borax-mediated Anti-tumor Activity through High-throughput Technology.

Current molecular medicine·2026
Same journal

Broad-Spectrum Vaccines: Challenges and Opportunities (A Systematic Review).

Current molecular medicine·2026
See all related articles

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Bacterial plasmids encoding foreign antigens have significantly advanced vaccine design in the past decade.
  • Plasmid DNA vaccination has shown promise in experimental models against viral, bacterial, and parasitic infections, as well as in modulating autoimmune diseases and cancer progression.

Purpose of the Study:

  • To review the current state and potential of plasmid DNA vaccines.
  • To discuss the optimization of DNA vaccine delivery and immune response modulation.
  • To highlight the safety and efficacy of DNA vaccines in pre-clinical and clinical settings.

Main Methods:

  • Review of pre-clinical and clinical trial data on plasmid DNA vaccines.
  • Analysis of immune mechanisms underlying DNA vaccine-induced responses.

Related Experiment Videos

  • Exploration of various delivery routes and modes for DNA vaccines.

    • Main Results:

    • DNA vaccines have demonstrated efficacy in animal models against a range of diseases.
    • They can induce either protective immune responses or immunoregulatory/immunosuppressive effects.
    • Pre-clinical and early clinical trials indicate DNA vaccines are safe and well-tolerated.

    Conclusions:

    • Plasmid DNA vaccines represent a versatile and continuously optimized vaccine modality.
    • While safe and effective in animal models, their efficacy in human trials requires further improvement.
    • Ongoing research focuses on optimizing DNA vaccine design and delivery for broader clinical application.